VERTEX PHARMACEUTICALS INC / MA ($VRTX)
McKechnie Duncan โ EVP, Chief Commercial Officer
Shares
1,148
Price
$483.75
Total Value
$555,345.00
Nearby Earnings
Feb 9, 2026
EPS:Est: 5.05
Revenue:Est: $3.18B
Feb 12, 2026
EPS:5.03 (est: 5.11)-1.6%
Revenue:$3.23B (est: $3.18B)+1.4%
Transaction Details
| Insider | McKechnie Duncan |
|---|---|
| Title | EVP, Chief Commercial Officer |
| Transaction Date | Feb 17, 2026 |
| Transaction Code | F Tax Withholding |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 17, 2026 |
| Shares Purchased | 1,148 |
| Price per Share | $483.75 |
| Total Value | $555,345.00 |
| Shares Owned After | 23,342 |
| Derivative | No |
| Accession Number | 0000875320-26-000094 |
| Document | View SEC Filing |